Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0.263. It has been cited 4 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0217
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NIAID NIH HHS
Grant: R21 AI154343
NIAID NIH HHS
Grant: R21 AI183057
NIAID NIH HHS
Grant: R21 AI130504
NHLBI NIH HHS
Grant: R01 HL136707
National Institutes of Health
Grant: 1R21AI130504-01
Anti-NET autoantibodies in cystic fibrosis
National Institutes of Health
Grant: 5R01HL136707-04
Neutrophil extracellular traps in cystic fibrosis
National Institutes of Health
Grant: 1R21AI154343-01A1
Association of Staphylococcus aureus infection with autoimmunity in cystic fibrosis
FWCI
0.65
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes